-
1
-
-
77349095475
-
New hope for advanced gastric cancer
-
Lancet Oncology
-
The Lancet Oncology. New hope for advanced gastric cancer. Lancet Oncol 2010;11(3):211.
-
(2010)
Lancet Oncol
, vol.11
, Issue.3
, pp. 211
-
-
-
2
-
-
0029978656
-
Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States)
-
DOI 10.1007/BF00052937
-
Farrow D, Vaughan T. Determinants of survival following the diagnosis of esophageal adenocarcinoma. Cancer Causes Control 1996;7(3):322-7. (Pubitemid 26163884)
-
(1996)
Cancer Causes and Control
, vol.7
, Issue.3
, pp. 322-327
-
-
Farrow, D.C.1
Vaughan, T.L.2
-
3
-
-
50849123421
-
HER2 in gastric cancer: A new prognostic factor and a novel therapeutic target
-
Gravalos G, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008;19(9):1523-9.
-
(2008)
Ann Oncol
, vol.19
, Issue.9
, pp. 1523-1529
-
-
Gravalos, G.1
Jimeno, A.2
-
4
-
-
0022647432
-
The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity
-
Akiyama T, Sudo C, Oogawara H, Toyoshima K, Yyamamoto T. The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986;232:1644-6. (Pubitemid 16095607)
-
(1986)
Science
, vol.232
, Issue.4758
, pp. 1644-1646
-
-
Akiyama, T.1
Sudo, C.2
Ogawara, H.3
-
5
-
-
0022399581
-
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
-
Coussens L, Yyang-Feng TL, Lliao YC. Tyrosine kinase receptor with extensive homology to EGegF receptor shares chromosomal location with neu oncogene. Science 1985;230:1132-9. (Pubitemid 16169997)
-
(1985)
Science
, vol.230
, Issue.4730
, pp. 1132-1139
-
-
Coussens, L.1
Yang-Feng, T.L.2
Liao, Y.-C.3
-
6
-
-
0038470907
-
Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer
-
DOI 10.1093/jjco/hyg039
-
Lee KE, Lee HJ, Kim YH. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 2003;33:173-9. (Pubitemid 43102860)
-
(2003)
Japanese Journal of Clinical Oncology
, vol.33
, Issue.4
, pp. 173-179
-
-
Lee, K.E.1
Lee, H.-J.2
Kim, Y.H.3
Yu, H.J.4
Yang, H.-K.5
Kim, W.-H.6
Lee, K.U.7
Choe, K.J.8
Kim, J.-P.9
-
7
-
-
73649096906
-
HER 2/neu protein expression in gastric canceris associated with poor survival
-
Xie SD, Xu CY, Shen JG, et al. HER 2/neu protein expression in gastric canceris associated with poor survival. Molecular Medicine REPORTS 2009;2:943-6.
-
(2009)
Molecular Medicine REPORTS
, vol.2
, pp. 943-946
-
-
Xie, S.D.1
Xu, C.Y.2
Shen, J.G.3
-
8
-
-
0031944290
-
Regulation of immune responses by TGF-beta
-
Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
-
(1998)
Annu Rev Immunol
, vol.16
, pp. 137-161
-
-
Letterio, J.J.1
Roberts, A.B.2
-
9
-
-
0031710654
-
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences
-
Fujiwara T, Stolker JM, Watanabe T, et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998;153:1063-78. (Pubitemid 28465830)
-
(1998)
American Journal of Pathology
, vol.153
, Issue.4
, pp. 1063-1078
-
-
Fujiwara, T.1
Stolker, J.M.2
Watanabe, T.3
Rashid, A.4
Longo, P.5
Eshleman, J.R.6
Booker, S.7
Lynch, H.T.8
Jass, J.R.9
Green, J.S.10
Kim, H.11
Jen, J.12
Vogelstein, B.13
Hamilton, S.R.14
-
10
-
-
0030183051
-
Tumor suppressor activity of the TGF-β pathway in human cancers
-
DOI 10.1016/1359-6101(96)00001-9, PII S1359610196000019
-
Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF β pathway in human cancers. Cytokine Growth Factor Rev 1996;7:93-102. (Pubitemid 27202668)
-
(1996)
Cytokine and Growth Factor Reviews
, vol.7
, Issue.1
, pp. 93-102
-
-
Markowitz, S.D.1
Roberts, A.B.2
-
11
-
-
33845547203
-
Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: Friends or enemies?
-
DOI 10.1007/s10555-006-9010-6, Special Issue on Pro-inflammatory Cytokines in Cancer
-
Shurin MR, Shurin GV, Lokshin A, et al. Intratumoral cytokines/ chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis 2006;25:333-56. (Pubitemid 44922354)
-
(2006)
Cancer and Metastasis Reviews
, vol.25
, Issue.3
, pp. 333-356
-
-
Shurin, M.R.1
Shurin, G.V.2
Lokshin, A.3
Yurkovetsky, Z.R.4
Gutkin, D.W.5
Chatta, G.6
Zhong, H.7
Han, B.8
Ferris, R.L.9
-
12
-
-
0034075926
-
Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer
-
Ebert M P, Yu J, Miehlke S, et al. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer 2000;82(11):1795-800. (Pubitemid 30307391)
-
(2000)
British Journal of Cancer
, vol.82
, Issue.11
, pp. 1795-1800
-
-
Ebert, M.P.A.1
Yu, J.2
Miehlke, S.3
Fei, G.4
Lendeckel, U.5
Ridwelski, K.6
Stolte, M.7
Bayerdorffer, E.8
Malfertheiner, P.9
-
13
-
-
0029868841
-
Negative regulation of cell growth by TGFβ
-
DOI 10.1016/0304-419X(95)00009-5
-
Polyak K. Negative regulation of cell growth by TGF beta. Bichem Biophys Acta 1996;1242:185-99. (Pubitemid 26106293)
-
(1996)
Biochimica et Biophysica Acta - Reviews on Cancer
, vol.1242
, Issue.3
, pp. 185-199
-
-
Polyak, K.1
-
14
-
-
0027930489
-
1 with tumor progression
-
Hsu S, Huang F, Hafez M, Winawer S, Friedman E. Colon carcinoma cells switch their response to transforming growth factor β with tumor progression. Cell Growth Differ 1994;5:267-75. (Pubitemid 24251376)
-
(1994)
Cell Growth and Differentiation
, vol.5
, Issue.3
, pp. 267-275
-
-
Hsu, S.1
Huang, F.2
Hafez, M.3
Winawer, S.4
Friedman, E.5
-
15
-
-
0242552529
-
Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1
-
DOI 10.1128/MCB.23.23.8691-8703.2003
-
Muraoka RS, Koh Y, Roebuck LR, et al. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor betal. Mol Cell Biol 2003;23:8691-703. (Pubitemid 37433371)
-
(2003)
Molecular and Cellular Biology
, vol.23
, Issue.23
, pp. 8691-8703
-
-
Muraoka, R.S.1
Koh, Y.2
Roebuck, L.R.3
Sanders, M.E.4
Brantley-Sieders, D.5
Gorska, A.E.6
Moses, H.L.7
Arteaga, C.L.8
-
16
-
-
36749121992
-
HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells
-
Wilson CA, Cajulis EE, Green JL, et al. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells. Breast Cancer Res 2005;7:R1058-79.
-
(2005)
Breast Cancer Res
, vol.7
-
-
Wilson, C.A.1
Cajulis, E.E.2
Green, J.L.3
-
18
-
-
12644292106
-
The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification
-
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
-
(1965)
Acta Pathol Microbiol Scand
, vol.64
, pp. 31-49
-
-
Lauren, P.1
-
19
-
-
0034929997
-
The HER-2/neu oncogene in tumors of the gastrointestinal tract
-
DOI 10.1081/CNV-100103852
-
Ross JS, McKenna BJ. The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001;19; 554-68. (Pubitemid 32619394)
-
(2001)
Cancer Investigation
, vol.19
, Issue.5
, pp. 554-568
-
-
Ross, J.S.1
McKenna, B.J.2
-
20
-
-
0036354718
-
Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin
-
DOI 10.1006/jsre.2001.6305
-
Shinohara H, Morita S, Kawai M, et al. Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin. J Surg Res 2002;102:169-77. (Pubitemid 34969464)
-
(2002)
Journal of Surgical Research
, vol.102
, Issue.2
, pp. 169-177
-
-
Shinohara, H.1
Morita, S.2
Kawai, M.3
Miyamoto, A.4
Sonoda, T.5
Pastan, I.6
Tanigawa, N.7
-
21
-
-
0034118639
-
C-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems
-
Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW, Heiss MM. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumorassociated protease systems. J Clin Oncol 2000;18:2201-9. (Pubitemid 30350211)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.11
, pp. 2201-2209
-
-
Allgayer, H.1
Babic, R.2
Gruetzner, K.U.3
Tarabichi, A.4
Schildberg, F.W.5
Heiss, M.M.6
-
22
-
-
47549090432
-
TGFbeta in cancer
-
Massagué J. TGFbeta in Cancer. Cell 2008;134(2):215-30.
-
(2008)
Cell
, vol.134
, Issue.2
, pp. 215-230
-
-
Massagué, J.1
-
23
-
-
78650196468
-
Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer
-
Lu B, Zhou YN, Li Q, Wu ZQ, Zhang ZY, Ji R, et al. Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer. Ai Zheng 2009;28(5):538-42.
-
(2009)
Ai Zheng
, vol.28
, Issue.5
, pp. 538-542
-
-
Lu, B.1
Zhou, Y.N.2
Li, Q.3
Wu, Z.Q.4
Zhang, Z.Y.5
Ji, R.6
-
24
-
-
0033570029
-
The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma
-
DOI 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0. CO;2-L
-
Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999;86:1455-62. (Pubitemid 29489778)
-
(1999)
Cancer
, vol.86
, Issue.8
, pp. 1455-1462
-
-
Saito, H.1
Tsujitani, S.2
Oka, S.3
Kondo, A.4
Ikeguchi, M.5
Maeta, M.6
Kaibara, N.7
-
25
-
-
34547610616
-
Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients
-
DOI 10.1038/sj.bjc.6603877, PII 6603877
-
Hawinkels LJ, Verspaget HW, van Duijn W, van der Zon JM, Zuidwijk K, Kubben FJ, et al. Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer 2007;97(3):398-404. (Pubitemid 47196749)
-
(2007)
British Journal of Cancer
, vol.97
, Issue.3
, pp. 398-404
-
-
Hawinkels, L.J.A.C.1
Verspaget, H.W.2
Van Duijn, W.3
Van Der Zon, J.M.4
Zuidwijk, K.5
Kubben, F.J.G.M.6
Verheijen, J.H.7
Hommes, D.W.8
Lamers, C.B.H.W.9
Sier, C.F.M.10
-
26
-
-
0030024536
-
High levels of transforming growth factor in patients with colorectal cancer: Association with disease progression
-
DOI 10.1053/gast.1996.v110.pm8566583
-
Tsushima H, Kawata S, Tamura S, et al. High levels of transforming growth factor b1 in patients with colorectal cancer: Association with disease progression. Gastroenterology 1996;110:375-82. (Pubitemid 26043869)
-
(1996)
Gastroenterology
, vol.110
, Issue.2
, pp. 375-382
-
-
Tsushima, H.1
Kawata, S.2
Tamura, S.3
Ito, N.4
Shirai, Y.5
Kiso, S.6
Imai, Y.7
Shimomukai, H.8
Nomura, Y.9
Matsuda, Y.10
Matsuzawa, Y.11
-
27
-
-
0027053058
-
1 associates with disease progression in human breast cancer
-
Gorsch SM, Memoli VA, Stukel TA, et al. Immunohistochemical staining for transforming growth factor b1 associates with disease progression in human breast cancer. Cancer Res 1992;52:6949-52. (Pubitemid 23006305)
-
(1992)
Cancer Research
, vol.52
, Issue.24
, pp. 6949-6952
-
-
Gorsch, S.M.1
Memoli, V.A.2
Stukel, T.A.3
Gold, L.I.4
Arrick, B.A.5
|